- Home
- WEA vs ZTEK Comparison
WEA vs ZTEK Comparison
Compare WEA & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEA
- ZTEK
- Stock Information
- Founded
- WEA 2002
- ZTEK 2008
- Country
- WEA United States
- ZTEK Canada
- Employees
- WEA N/A
- ZTEK N/A
- Industry
- WEA Trusts Except Educational Religious and Charitable
- ZTEK Major Chemicals
- Sector
- WEA Finance
- ZTEK Industrials
- Exchange
- WEA Nasdaq
- ZTEK Nasdaq
- Market Cap
- WEA 130.9M
- ZTEK 116.6M
- IPO Year
- WEA N/A
- ZTEK N/A
- Fundamental
- Price
- WEA $10.77
- ZTEK $0.86
- Analyst Decision
- WEA
- ZTEK
- Analyst Count
- WEA 0
- ZTEK 0
- Target Price
- WEA N/A
- ZTEK N/A
- AVG Volume (30 Days)
- WEA 46.1K
- ZTEK 37.3K
- Earning Date
- WEA 01-01-0001
- ZTEK 02-11-2025
- Dividend Yield
- WEA 7.87%
- ZTEK N/A
- EPS Growth
- WEA N/A
- ZTEK N/A
- EPS
- WEA N/A
- ZTEK N/A
- Revenue
- WEA N/A
- ZTEK $29,132.00
- Revenue This Year
- WEA N/A
- ZTEK N/A
- Revenue Next Year
- WEA N/A
- ZTEK N/A
- P/E Ratio
- WEA N/A
- ZTEK N/A
- Revenue Growth
- WEA N/A
- ZTEK 8.15
- 52 Week Low
- WEA $9.60
- ZTEK $0.50
- 52 Week High
- WEA $11.29
- ZTEK $1.59
- Technical
- Relative Strength Index (RSI)
- WEA 36.14
- ZTEK 34.48
- Support Level
- WEA $11.00
- ZTEK $1.05
- Resistance Level
- WEA $11.01
- ZTEK $1.16
- Average True Range (ATR)
- WEA 0.14
- ZTEK 0.08
- MACD
- WEA -0.03
- ZTEK -0.04
- Stochastic Oscillator
- WEA 19.59
- ZTEK 8.57
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.